Clorox Co: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 5, 2025 and accepted by EDGAR at May 5, 2025, 16:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $1.67bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-07-01 to 2025-03-31 | $5.12bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $924.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-07-01 to 2025-03-31 | $2.83bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-01-01 to 2025-03-31 | $744.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-07-01 to 2025-03-31 | $2.29bn | us-gaap:GrossProfit |
| Research and development | 3 months2025-01-01 to 2025-03-31 | $27.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-07-01 to 2025-03-31 | $89.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $267.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-07-01 to 2025-03-31 | $828.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $23.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2024-07-01 to 2025-03-31 | $66.0m | us-gaap:InterestExpense |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $63.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-07-01 to 2025-03-31 | $180.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | $186.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | $478.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $1.50 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | $3.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | $1.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | $3.87 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 124,066,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 124,468,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | $687.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-07-01 to 2025-03-31 | $145.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2024-07-01 to 2025-03-31 | $452.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2024-07-01 to 2025-03-31 | $257.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-31 | $226.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $1.59bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $5.51bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $2.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $5.32bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-03-31 | $2.48bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2025-03-31 | $54.0m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2025-03-31 | $27.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000021076-25-000023. Last ingested by Listed: Nov 5, 2026, 18:00 ET. Listed shows no prices and gives no investment advice.